CClinicalTrials.gg
CompletedNCT01943747IMPRESSUpdated Aug 20, 2014

International Multicentre Prevalence Study on Sepsis

An observational study in Severe Sepsis and Septic Shock, sponsored by European Society of Intensive Care Medicine. Completed at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-08-20.

Sponsored by European Society of Intensive Care Medicine · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
1,000
Ages
18 Years and older
Sex
All
01

Study summary

To mark 10 years of the Surviving Sepsis Campaign (SSC), and timed to coincide with World Sepsis Day, on September 13, 2013, the SSC, ESICM and SCCM will be conducting an international point prevalence study of severe sepsis and septic shock. The goal of this project is to determine the world wide burden of severe sepsis and define current practices of sepsis care internationally. The study is a simple data collection exercise for patients presenting with either severe sepsis or septic shock on World Sepsis Day.

Read the detailed description

De---identified patient---level data will be collected on patients presenting to a participating intensive care unit or emergency department with severe sepsis or septic shock over a 24 hour period from 00:00 to 24:00 November 07, 2013. De---identified data that is already collected as part of routine clinical care will be collected for this study. Data to be collected includes hospital and ICU characteristics, patient characteristics, severity of illness, and adherence to SSC bundle elements and mortality. It will take between 30---60 minutes to collect and enter data for each patient admitted with severe sepsis or septic shock over the 24 hours study period.

02

Conditions studied

  • Severe Sepsis
  • Septic Shock

Keywords

  • sepsis
  • severe sepsis
  • septic shock
  • infection
  • organ dysfunction
  • quality improvement
03

In context

Sepsis

1,899 studies on the registry are indexed under Sepsis; 462 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 160 across 931 observational studies indexed under Sepsis.

Browse Sepsis studies →

Lead sponsor

European Society of Intensive Care Medicine is the lead sponsor of 9 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

patients presenting with either severe sepsis or septic shock

Inclusion criteria

To be eligible patients must have all of the following:

  • Must be admitted or transferred to either the ED or an Intensive Care Unit.
  • Have a high clinical suspicion of an infection
  • Have sepsis as defined by an infection together with two or more SIRS criteria
  • Evidence of acute organ dysfunction and/or Shock.

Exclusion criteria

Exclusion Criteria:

  • Patients less than 18 years of age
  • Patients in whom the sepsis has been present from before the beginning of the study period
  • Any patients previously included in the study during the same study period
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
1,000 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. 28-Day Mortality

    Time frame: one week

Secondary outcomes

  1. Organ Failure

    Time frame: one week

Other outcomes

  1. Length of Stay in the Hospital

    Time frame: one week

07

Study locations

1 site
  • All centres willing to contribute are welcome.
    Brussels, Belgium
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 20, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01943747
Lead sponsor
European Society of Intensive Care Medicine
Collaborators
Society of Critical Care Medicine (SCCM)
Responsible party
Sponsor
First posted
Sep 17, 2013
Start date
Nov 2013
Primary completion
Nov 2013
Completion
Jan 2014
Last update
Aug 20, 2014

Study contacts

Andrew RHODES, MD, PhD
principal investigator · European Society of Intensive Care Medicine

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion